Non-cAMP-mediated bronchial arterial vasodilation in response to inhaled β-agonists

Journal of Applied Physiology

Volumn 84, Issue 1, 1998, Pages 215-221

  Carvalho, Paula ^a   Johnson, Shane R ^b   Charan, Nirmal B ^b  

^a Boise VA Medical Center   (United States)

^b NONE

Author keywords

Adenosine 3',5' cyclic monophosphate; Bronchial circulation; Nitric oxide; adrenoreceptor agonists

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTERY DILATATION; ARTICLE; BRONCHIAL ARTERY; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; INHALATIONAL DRUG ADMINISTRATION; LUNG BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SHEEP; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0031933787     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1998.84.1.215     Document Type: Article

References (28)

1. Arowolo, R. P. A., and P. Eyre. Preliminary pharmacological characterization of the bovine isolated artery strip: a new preparation. Br. J. Pharmacol. 68: 283-288, 1982.
2. Barker, J. A., A. D. Chediak, H. J. Baier, and A. Wanner. Tracheal mucosal blood flow responses to autonomic agonists. J. Appl. Physiol. 65: 829-834, 1988.
3. Carstairs, J. R., A. J. Nimmo, and P. J. Barnes. Autoradiographic localization of β-adrenoreceptors in the human lung. Eur. J. Pharmacol. 103: 189-190, 1984.
4. Charan, N. B., S. R. Johnson, S. Lakshminarayan, W. H. Thompson, and P. Carvalho. Nitric oxide and β-adrenergic agonist-induced bronchial arterial vasodilation. J. Appl. Physiol. 82: 686-692, 1997.
5. Charan, N. B., G. M. Turk, and R. Dhand. Gross and subgross anatomy of the bronchial circulation in sheep. J. Appl. Physiol. 57: 658-664, 1984.
6. Charan, N. B., G. M. Turk, and R. Ripley. Measurement of bronchial arterial blood flow and bronchovascular resistance in sheep. J. Appl. Physiol. 59: 305-308, 1985.
7. Corboz, M. R., S. T. Ballard, S. K. Inglis, and A. E. Taylor. Tracheal microvascular responses to β-adrenergic stimulation in anesthetized rats. Am. J. Respir. Crit. Care Med. 153: 1093-1097, 1996.
8. Davisson, R. L., J. N. Bates, A. K. Johnson, and S. J. Lewis. Use-dependent loss of acetylcholine and bradykinin-mediated vasodilation after nitric oxide synthase inhibition. Evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells. Hypertension 28: 354-360, 1996.
9. Davisson, R. L., R. A. Shaffer, A. K. Johnson, and S. J. Lewis. Use-dependent loss of active sympathetic neurogenic vasodilation after nitric oxide synthase inhibition in conscious rats. Hypertension 28: 347-353, 1996.
10. G-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5′-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br. J. Pharmacol. 103: 1725-1732, 1991.
11. Graves, J., and L. Poston. β-Adrenoreceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide. Br. J. Pharmacol. 108: 631-637, 1993.
12. Gray, D. W., and I. Marshall. Novel signal transduction pathway mediating endothelium-dependent β-adrenoreceptor vasorelaxation in rat thoracic aorta. Br. J. Pharmacol. 107: 684-690, 1992.
13. Heeson, B. J., and J. G. R. DeMey. Effect of cyclic AMP-affecting agents on contractile reactivity of isolated mesenteric and renal resistance arteries of the rat. Br. J. Pharmacol. 101: 859-864, 1990.
14. Ignarro, I. J. Nitric oxide: a novel signal transduction mechanism for transcellular communication. Hypertension 16: 477-483, 1990.
15. Imai, T., Y. Hirata, K. Kanno, and F. Marumo. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J. Clin. Invest. 93: 543-549, 1994.
16. Kukovetz, W. R., G. Poch, and S. Holzmann. Cyclic nucleotides and relaxation of vascular smooth muscle. In: Vasodilatation, edited by P. M. Vanhoutte and I. Leuzen. New York: Raven, 1981, p. 339-353.
17. Laitinen, L. A., M. A. Laitinen, and J. G. Widdicombe. Dose-related effects of pharmacological mediators on tracheal vascular resistance in dogs. Br. J. Pharmacol. 92: 703-709, 1987.
18. Lincoln, T. M., and T. L. Cornwell. Intracellular cyclic GMP receptor proteins. FASEB J. 7: 328-338, 1993.
19. McLaughlin, R. F. Bronchial artery distribution in various mammals and in humans. Am. Rev. Respir. Dis. 128: 557-558, 1983.
20. Moncada, S., and A. Higgs. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012, 1993.
21. Muhl, H., D. Kunz, and J. Pfeilschifter. Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP. Br. J. Pharmacol. 112: 1-8, 1994.
22. Parsons, G. H., G. C. Kramer, D. P. Link, B. M. T. Lantz, R. A. Gunther, J. F. Green, and C. E. Cross. Studies of reactivity and distribution of bronchial blood flow in sheep. Chest 87: 180S-182S, 1985.
23. Rebich, S., J. O. Devine, and W. M. Armstead. Role of nitric oxide and cAMP in β-adrenoreceptor-induced pial artery vasodilation. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H1071-H1076, 1995.
24. Rubanyi, G., and P. M. Vanhoutte. Endothelium-removal decreases relaxations of canine coronary arteries caused by β-adrenergic agonists and adenosine. J. Cardiovasc. Pharmacol. 7: 139-144, 1985.
25. 2+-dependent intracellular signaling mechanisms in brain capillary endothelial cells. J. Neurochem. 62: 2269-2274, 1994.
26. Wang, Y.-X., K. S. Poon, D. J. Randall, and C. C. Y. Pang. Endothelium-derived nitric oxide partially mediates salbutamol-induced vasodilatations. Eur. J. Pharmacol. 250: 335-340, 1993.
27. Wanner, A., J. A. Barker, W. M. Long, A. T. Mariassy, and A. D. Chediak. Measurement of airway mucosal perfusion and tissue water volume with an inert soluble gas method. J. Appl. Physiol. 65: 264-271, 1988
28. White, S. W., E. J. Hennessy, A. W. Quail, J. Brock, and W. L. Porges. Effect of nitric oxide synthase inhibition on control of bronchoesophageal circulation in awake dogs (Abstract). Proc. Aust. Physiol. Pharmacol. Soc. 25: 62P, 1994.